Contact
Please use this form to send email to PR contact of this press release:
OXIDIEN PHARMACEUTICALS TO PRESENT AT THE 2020 BIO CEO & INVESTOR CONFERENCE
TO:
Helena Cowley
Oxidien Pharmaceuticals
+1 352-672-5320